Morgan Stanley raised the firm’s price target on Haleon (HLN) to 440 GBp from 420 GBp and keeps an Overweight rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLN:
- Haleon: Solid Underlying Growth and Margin Strength Support Buy Rating Despite Near-Term Cold & Flu Headwinds
- Haleon PLC: Weaker Near‑Term Sales but Strengthening Margins Support Medium‑Term Buy Rating
- Haleon price target lowered to 510 GBp from 517 GBp at Berenberg
- Haleon Tests New Sensitivity Toothpaste in China: What Investors Should Watch
- Haleon upgraded to Overweight from Equal Weight at Barclays